1. Home
  2. NXST vs TVTX Comparison

NXST vs TVTX Comparison

Compare NXST & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

N/A

Current Price

$196.51

Market Cap

5.3B

Sector

Industrials

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$47.21

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXST
TVTX
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.7B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
NXST
TVTX
Price
$196.51
$47.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
★ $245.38
$73.43
AVG Volume (30 Days)
348.8K
★ 1.9M
Earning Date
11-05-2026
11-02-2026
Dividend Yield
★ 3.70%
N/A
EPS Growth
N/A
★ 92.89
EPS
★ 16.62
N/A
Revenue
★ $4,949,000,000.00
N/A
Revenue This Year
$60.76
$55.96
Revenue Next Year
N/A
$48.63
P/E Ratio
$12.08
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$153.17
$22.59
52 Week High
$254.30
$68.73

Technical Indicators

Market Signals
Indicator
NXST
TVTX
Relative Strength Index (RSI) 60.45 35.71
Support Level $175.53 $41.75
Resistance Level $198.56 $48.60
Average True Range (ATR) 7.85 2.55
MACD 0.05 -0.02
Stochastic Oscillator 60.62 29.52

Price Performance

Historical Comparison
NXST
TVTX

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed, Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN America), a cable news network, 75% of the fifth national broadcaster, The CW, and a 31% stake in Food Network and Cooking Channel.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: